Skip to Content
Merck
  • Short Chain Fatty Acids (SCFA) Reprogram Gene Expression in Human Malignant Epithelial and Lymphoid Cells.

Short Chain Fatty Acids (SCFA) Reprogram Gene Expression in Human Malignant Epithelial and Lymphoid Cells.

PloS one (2016-07-22)
Lidiia Astakhova, Mtakai Ngara, Olga Babich, Aleksandr Prosekov, Lyudmila Asyakina, Lyubov Dyshlyuk, Tore Midtvedt, Xiaoying Zhou, Ingemar Ernberg, Liudmila Matskova
ABSTRACT

The effect of short chain fatty acids (SCFAs) on gene expression in human, malignant cell lines was investigated, with a focus on signaling pathways. The commensal microbial flora produce high levels of SCFAs with established physiologic effects in humans. The most abundant SCFA metabolite in the human microflora is n-butyric acid. It is well known to activate endogenous latent Epstein-Barr virus (EBV), that was used as a reference read out system and extended to EBV+ epithelial cancer cell lines. N-butyric acid and its salt induced inflammatory and apoptotic responses in tumor cells of epithelial and lymphoid origin. Epithelial cell migration was inhibited. The n-butyric gene activation was reduced by knock-down of the cell membrane transporters MCT-1 and -4 by siRNA. N-butyric acid show biologically significant effects on several important cellular functions, also with relevance for tumor cell phenotype.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-PARP (214/215) cleavage site Antibody, Chemicon®, from rabbit